Bookmark and Share

$CLXPF Activists in Spokane, Washington, Call for Decriminalization of Psilocybin

Local activists from Decriminalize Spokane recently filed an initiative that, if approved, may make Spokane the latest city to decriminalize hallucinogenic mushrooms in the United States.

The measure would prohibit officials from using the city’s resources or funds to enforce laws that impose criminal penalties for the distribution, growing, transportation, possession or use of psilocybin mushrooms. This is in addition to making the distribution, growing and personal possession of psilocybin for individuals aged 21 and over among the lowest enforcement priorities of law enforcement.

Decriminalize Spokane plans to qualify the measure for the city’s ballot. The initiative includes terms forbidding the display or use of psilocybin mushrooms in public spaces as well as a section that directs attention to the scientific research conducted on psilocybin’s therapeutic potential and any low health risks that the psychedelic fungi might pose.

The proposal states that psilocybin can be used to effectively treat trauma, addiction, cluster headaches and depression as well as decrease prison recidivism and reduce end-of-life anxiety for terminal cancer and hospice patients.

The proposal was presented to the City Council earlier in February, with legislators being provided with the option of passing the bill themselves, approving the petition and allowing the voters to vote on it, or declining it and suggesting an alternative.

Legislators decided not to act on the measure, which left the task up to the city officials to make sure the proposal’s language is in accordance with the law before clearing it for signature collection. If activists are successful in gathering enough signatures from registered voters, the proposal could be presented to voters by November 2021. The activists require 3,477 signatures in order for the measure to qualify for the ballot.

Chief petitioner Mason Lord stated in an interview that the measure focused mainly on safety and highlighted the fact that some legal substances, such as alcohol, were considerably more dangerous.

Earlier in 2019, Denver became the first city in the country to decriminalize magic mushrooms through a citizen measure. Since then, other cities in the nation, including CambridgeSomervilleWashington D.C., Ann ArborSanta Cruz and Oakland, have decriminalized various fungi and plant-based psychedelics,

During the 2020 November elections, voters in Oregon passed historic measures to decriminalize drugs and legalize the use of psilocybin for therapeutic purposes. Additionally, lawmakers in VirginiaWashington StateMissouriKansasHawaiiFlorida, Connecticut and California are also considering drug policy and psychedelics reform bills for this year’s session.

An objective look at the developments in the psychedelics field shows that the movements to legalize or at least decriminalize psychedelics have a basis in science. For example, Cybin Inc. (NEO: CYBN) (OTC: CLXPF) has four candidate psychedelic drug formulations in various stages of development, and all these drugs have potential to revolutionize how mental health conditions are treated.

NOTE TO INVESTORS: The latest news and updates relating to Cybin Inc. (NEO: CYBN) (OTC: CLXPF) are available in the company’s newsroom at

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published:

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
415.949.5050 Office

PsychedelicNewsWire is part of the InvestorBrandNetwork.

Friday, March 12th, 2021 Uncategorized
Top Small Cap Market News